Eisai/Biogen’s Leqembi Will Launch Below Aduhelm At $26,500 Per Year

Available For Commercially Insured Patients By Mid-Month

 
• By Mandy Jackson
  
Brown price tag on wooden background
Eisai determined Leqembi's "societal value" is as high as $37,600 but set its list price at $26,500 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip